insufficient data

Evidence network for deaths (OS)

1NSABP B-59/GBG 96-GeparDouze, 2018carboplatinpegylated liposomal doxorubicin and cyclophosphamideatezolizumab based treatmentdirect evidencenetwork meta-analysis
T vs. C carboplatinpegylated liposomal doxorubicin and cyclophosphamideatezolizumab based treatment
carboplatin---NANA
pegylated liposomal doxorubicin and cyclophosphamideNA---NA
atezolizumab based treatmentNANA---

pathologies: 96 - treatments: 851,361,602,1070,671,865,744,696,1083,1281,1282,1283,1082,866 result logic